How Does Duac Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Key Takeaways: How Duac Works
- Active Ingredients: Clindamycin phosphate (10 mg/g) and anhydrous benzoyl peroxide (30 mg/g).
- Primary Actions: Clindamycin inhibits Cutibacterium acnes protein synthesis; benzoyl peroxide delivers keratolytic and antimicrobial effects via free oxygen radicals.
- Onset & Duration: Visible improvement usually begins after 2–5 weeks; treatment is recommended for up to 12 weeks.
- Absorption & Metabolism: Minimal systemic absorption (<5%). Clindamycin is metabolised in the liver; benzoyl peroxide is converted to benzoic acid and excreted renally.
- Key Advantage: The combination reduces antibiotic resistance risk because benzoyl peroxide kills bacteria through a non‑specific oxidative mechanism.
Duac Once Daily Gel combines a topical antibiotic (clindamycin) with a potent keratolytic and antimicrobial agent (benzoyl peroxide). This dual‑action formula targets both the bacterial cause of acne and the abnormal follicular keratinisation that leads to comedones and inflammatory lesions.
Important Medical Advice
Stop using Duac and seek immediate medical attention if you develop severe diarrhoea, abdominal cramps, or signs of an allergic reaction (swelling of face/lips, nettle rash, difficulty breathing). Severe skin irritation (burning, peeling, intense redness) also requires stopping the gel and consulting your doctor. Avoid contact with eyes, mouth, and broken skin; if accidental contact occurs, rinse thoroughly with water.
Chemical Composition & Active Ingredients
Duac Once Daily Gel is a fixed‑dose combination of two complementary active substances formulated in a hydroalcoholic gel base. Each gram of gel delivers 10 mg of clindamycin (as clindamycin phosphate) and 30 mg of anhydrous benzoyl peroxide (as hydrous benzoyl peroxide). The excipients include carbomer, dimeticone, disodium lauryl sulfosuccinate, disodium edetate, glycerol, colloidal hydrated silica, poloxamer 182, purified water, and sodium hydroxide to adjust pH.
Structural Details & Pharmaceutical Properties
Methyl 7-chloro-6,7,8-trideoxy-6-[[(1S,2S)-2-hydroxy-1-methyl-2-[(2S,5R)-5-(methylsulfanyl)oxolan-2-yl]ethyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside 2-(dihydrogen phosphate)
A semisynthetic lincosamide antibiotic. The phosphate ester is inactive until hydrolysed to active clindamycin by skin phosphatases, which then binds to bacterial ribosomes. Its lipophilic nature enhances follicular penetration.
Dibenzoyl peroxide (C₁₄H₁₀O₄)
A lipophilic organic peroxide. Upon application, it releases free oxygen radicals that oxidise bacterial proteins and lipids, exerting broad‑spectrum antimicrobial activity. It also promotes desquamation of follicular keratinocytes, reducing microcomedone formation.
Key Physicochemical Properties
| Property | Clindamycin (active form) | Benzoyl Peroxide |
|---|---|---|
| LogP (lipophilicity) | ~2.2 | ~3.0 |
| Molecular weight | 424.98 g/mol | 242.23 g/mol |
| Protein binding | ~90% (if absorbed) | Not applicable (metabolised locally) |
| Topical absorption | <5% of applied dose | <5% (converted to benzoic acid) |
🗒️ Formulation insight: The gel vehicle ensures rapid drying and minimises greasiness. The combination of poloxamer 182 and disodium lauryl sulfosuccinate enhances solubilisation and skin penetration, while the pH is adjusted to approximately 5.5–6.5 to maintain stability and reduce irritation.
Mechanism of Action: Dual Acne-Fighting Pathway
Duac exploits two independent yet complementary mechanisms to clear acne lesions. The synergy between clindamycin and benzoyl peroxide leads to faster resolution and helps prevent the emergence of antibiotic‑resistant bacterial strains.
- Clindamycin (antibacterial): After application, clindamycin phosphate is hydrolysed by skin phosphatases to active clindamycin. It penetrates the follicular epithelium and binds reversibly to the 50S ribosomal subunit of Cutibacterium acnes (formerly Propionibacterium acnes). This inhibits peptide chain elongation, halting bacterial protein synthesis and reducing the bacterial load that triggers inflammatory acne.
- Benzoyl Peroxide (keratolytic & antimicrobial): Benzoyl peroxide decomposes in the presence of water to release free oxygen radicals. These radicals oxidise bacterial cell membranes, DNA, and proteins, causing rapid, non‑specific killing of C. acnes (including clindamycin‑resistant strains). Simultaneously, it normalises follicular keratinisation by reducing corneocyte cohesion, thereby unblocking comedones and preventing new microcomedone formation.
| Feature | Clindamycin | Benzoyl Peroxide |
|---|---|---|
| Primary target | Bacterial ribosome (50S subunit) | Oxidative damage to bacterial cells |
| Onset of effect | 2‑4 weeks (bacterial reduction) | 1‑2 weeks (keratolytic) |
| Antibiotic resistance risk | Potential with monotherapy | None (non‑specific mechanism) |
| Anti‑inflammatory component | Indirect via reduced bacterial load | Direct inhibition of neutrophil chemotaxis |
🗒️ Clinical rationale: The combination of clindamycin and benzoyl peroxide in a single formulation reduces the likelihood of clindamycin resistance and provides more rapid clinical improvement than either agent alone.
Pharmacokinetics: Absorption & Skin Penetration
After topical application of Duac, systemic absorption of both components is minimal. Percutaneous absorption studies show that less than 5% of applied clindamycin reaches the systemic circulation, and benzoyl peroxide is almost completely metabolised in the skin.
Clindamycin absorption & distribution
Clindamycin phosphate is absorbed through the stratum corneum and follicular route. Once hydrolysed to clindamycin, it accumulates in the pilosebaceous unit. If absorbed systemically, clindamycin distributes widely (Vd ≈ 1.1 L/kg) and crosses the placenta. However, with topical use, serum levels are typically <0.5 ng/mL, far below those seen with oral administration.
Benzoyl peroxide dermal fate
Benzoyl peroxide is lipophilic and penetrates the follicular infundibulum. Within the stratum corneum, it is completely metabolised to benzoic acid, which is then absorbed systemically in trace amounts (<5% of dose). Benzoic acid is conjugated with glycine in the liver to form hippuric acid, which is rapidly excreted in urine.
Factors Affecting Skin Penetration
- Vehicle: The gel formulation with disodium lauryl sulfosuccinate and poloxamer 182 enhances follicular delivery.
- Skin barrier integrity: Damaged or inflamed skin may increase absorption; therefore Duac should not be applied to broken skin.
- Application technique: Applying a thin film to the entire affected area ensures uniform distribution without excessive systemic exposure.
Metabolic Effects & Elimination
The metabolic fate of Duac’s components differs markedly due to their chemical structures. Systemic metabolism is negligible under normal use, but the small amounts that enter the circulation follow well‑characterised pathways.
Clindamycin metabolism: If systemically absorbed, clindamycin undergoes hepatic biotransformation via CYP3A4 and other enzymes to form clindamycin sulfoxide and N‑demethylclindamycin, which are inactive. Excretion occurs primarily in urine (about 60% as metabolites) and faeces. The elimination half‑life is approximately 2–3 hours.
Benzoyl peroxide metabolism: Benzoyl peroxide is not absorbed intact. It is completely reduced in the skin to benzoic acid, which is conjugated with glycine to form hippuric acid. Hippuric acid is filtered by the kidneys and excreted rapidly; no accumulation occurs. No active metabolites are formed.
⚠️ Metabolic caution: Although systemic exposure is minimal, patients with severe hepatic or renal impairment should use Duac with caution because the theoretical risk of accumulation exists, especially if large areas are treated.
Clinical Efficacy in Acne Management
Duac is indicated for the topical treatment of mild to moderate acne vulgaris in adults and adolescents aged 12 years and older. Clinical trials have demonstrated that the combination gel significantly reduces both inflammatory (papules, pustules) and non‑inflammatory (open and closed comedones) lesions.
- Onset of action: In controlled studies, patients began to see noticeable improvement after 2–5 weeks of once‑daily application. Maximum benefit is typically observed by week 12.
- Superiority over monotherapy: Duac has been shown to reduce lesion counts by 60–70% after 12 weeks, which is statistically superior to either clindamycin or benzoyl peroxide alone.
- Resistance prevention: The inclusion of benzoyl peroxide significantly reduces the emergence of clindamycin‑resistant C. acnes strains, a key advantage over topical antibiotic monotherapy.
- Adherence: Once‑daily application improves patient compliance compared to twice‑daily regimens.
Treatment should not exceed 12 weeks without reassessment by a healthcare professional. If no improvement is seen after 8 weeks, alternative therapies should be considered.
Duac FAQs
How long does Duac take to work?
Most people start seeing improvement within 2–5 weeks. Use it consistently once daily for up to 12 weeks; stopping early may allow acne to return.
Can I use other acne products with Duac?
Avoid using medicated soaps, abrasive cleansers, or other topical acne treatments containing tretinoin, isotretinoin, or erythromycin, as they may increase irritation. If needed, use them at different times of the day.
Does Duac cause skin bleaching or stain clothes?
Yes, benzoyl peroxide can bleach hair, coloured fabrics (towels, bed linen, clothing), and carpets. Avoid contact with such materials until the gel is completely dry.
What should I do if I experience severe redness or peeling?
Mild irritation is common in the first weeks. If severe, reduce application frequency to every other day, use an oil‑free moisturiser, or pause treatment for a few days. See your doctor if irritation persists.
Can I use Duac if I am pregnant or breastfeeding?
Limited data exist. Your doctor will weigh the benefits against potential risks. Avoid applying to the breast area if breastfeeding. Consult your GP before use.
Need Duac with Professional Guidance?
If you have mild to moderate acne and believe Duac could be suitable, a UK‑registered doctor can review your skin condition and issue a prescription after an online consultation.
Secure Prescription & Next-Day Delivery
MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors
Start Acne ConsultationRelated Duac Guides
Medical Content Manager
Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.
Medical Doctor
Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 31 March 2026
Next Review: 30 September 2026
Published on: 31 March 2026
Last Updated: 31 March 2026